Broughton's Chief Commercial Officer, Andy Mooney, discusses the latest synthetic nicotine...
3 minute read
Broughton explains how the FDA’s new powers to regulate synthetic nicotine will impact the industry.
Broughton's Chief Scientific and Regulatory Officer, Dr Nveed Chaudhary has published an article on the recent FDA announcement on synthetic nicotine with the leading sector publication Tobacco Reporter.
Filter
Filter
Results - 150 Blogs
6 minute read
2022 will define the future of ENDS
Broughton's Chief Scientific and Regulatory Officer, Dr Nveed Chaudhary discusses what developments...
Broughton's Head of Regulatory Affairs, Lloyd Smart, and Regulatory Consultant, Xiangyin Wei...
2 minute read
Broughton collaborates with leading global pharmaceutical experts at DDL
Broughton's Director of Product Development Services, Dr Fozia Saleem, and Technical Sales...
2 minute read
What manufacturers should know about the medical route for vapor products to the U.K. market.
Broughton's Head of Regulatory Affairs, Lloyd Smart has recently published an article with the...
Broughton's Chief Scientific Officer, Chris Allen shares his opinion with Financial Times about...
Aligned with Broughton’s belief in realizing harm reduction, Principal Scientist, Frazer Lowe...
3 minute read
UK MHRA announce the latest guidance on ecigarettes
Broughton's Head of Regulatory Affairs, Lloyd Smart discusses the latest UK Medicines & Healthcare...
4 minute read
FDA final rule for PMTA applications
Broughton's Head of Regulatory Affairs, Lloyd Smart discusses Food and Drug Administration (FDA)...
Sign up to our newsletter
Ensure your business stays ahead of the competition by keeping up to date on the latest regulatory changes. Sign up for our newsletter to have the latest information and insights served directly to your inbox.